Clarinex (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the Clarinex drug offered from Merck Sharp & Dohme Corp.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | Desloratadine |
SUBSTANCE NAME: | DESLORATADINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-12-21 |
END MARKETING DATE: | 0000-00-00 |
Clarinex HUMAN PRESCRIPTION DRUG Details:
Item Description | Clarinex from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2001-12-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0085-1264_93a187a2-e0d1-4b5e-ae40-48142b1932bd |
PRODUCT NDC: | 0085-1264 |
APPLICATION NUMBER: | NDA021165 |
Other DESLORATADINE Pharmaceutical Manufacturers / Labelers: